Back to mobile site

Ascendis Pharma (ASND) Announces Proposed $400M Public Offering of ADSs

March 4, 2019 4:00 PM EST Send to a Friend
Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address unmet medical needs, today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login